You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Central Nervous System Neoplasm

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Seen on Brain Imaging in Pediatric Patients Following Proton

Recruiting
  • Malignant Central Nervous System Neoplasm
  • Malignant Skull Base Neoplasm
  • Medical Chart Review
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 6, 2023

Human Brain-Gut Axis and Gut Microbiome in Brain Lesions -

Not yet recruiting
  • Malignant Central Nervous System Neoplasm
  • Non-Interventional Study
  • Jacksonville, Florida
    Mayo Clinic in Florida
Oct 31, 2023

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • SC-CAR4BRAIN
  • Seattle, Washington
    Seattle Children's Hospital
Mar 3, 2023

Patients With Brain Tumors Undergoing Surgery

Recruiting
  • Central Nervous System Neoplasm
  • +3 more
  • Biospecimen Collection
  • Laboratory Biomarker Analysis
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 29, 2022

CNS Tumor, Cranial Nerve Disorder, Metastatic Malignant Tumor in the Brain Trial in Portland (Ferumoxytol, Gadolinium, Magnetic

Recruiting
  • Central Nervous System Neoplasm
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 2, 2022

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

Non-small Cell Lung Cancer With Central Nervous System

Recruiting
  • Lung Cancer With Central Nervous System Metastasis
  • lung cancer with brain /leptomeningeal metastasis
  • Taipei, Taiwan
    National Taiwan University Hospital
Sep 4, 2023

Malignant CNS Tumor Trial in Rochester (drug, other, procedure)

Not yet recruiting
  • Malignant Central Nervous System Neoplasm
  • Anhydrous Enol-oxaloacetate
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 31, 2023

Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United

Completed
  • Neurofibromatosis Type 1
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Los Angeles, California
  • +11 more
Apr 22, 2022

Sarcoma, Ovarian Tumor, CNS Tumor Trial in Villejuif (Pembrolizumab)

Active, not recruiting
  • Sarcoma
  • +6 more
  • Villejuif, France
    Gustave Roussy Cancer Campus
Mar 28, 2022

Recurrent Lymphoma, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan,

Active, not recruiting
Has Results
  • Recurrent Lymphoma
  • +5 more
  • Birmingham, Alabama
  • +19 more
Oct 20, 2022

Diffuse Midline Glioma, H3 K27M-Mutant, Metastatic Malignant Tumor in the CNS, Recurrent Diffuse Intrinsic Pontine Glioma Trial

Active, not recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +10 more
  • FACT Complex-targeting Curaxin CBL0137
  • Birmingham, Alabama
  • +19 more
Jun 29, 2022

Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

Completed
Has Results
  • Brain Stem Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +20 more
Jan 6, 2023

Malignant CNS Tumor Trial in Atlanta (Intensity-Modulated Proton Therapy, Magnetic Resonance Imaging)

Active, not recruiting
  • Malignant Central Nervous System Neoplasm
  • Intensity-Modulated Proton Therapy
  • Magnetic Resonance Imaging
  • Atlanta, Georgia
  • +1 more
Feb 28, 2022

CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)

Recruiting
  • Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Tumor, Lynch Syndrome Trial in Canada,

Withdrawn
  • Constitutional Mismatch Repair Deficiency Syndrome
  • +11 more
  • Biospecimen Collection
  • +2 more
  • Palo Alto, California
  • +8 more
Sep 9, 2022

Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • +3 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Scottsdale, Arizona
  • +2 more
Jan 4, 2023

Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in Beijing (GNC-038)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Jul 31, 2022

Patient Perceptions Around Quality of Care Through Telemedicine

Recruiting
  • Central Nervous System Neoplasm
  • +3 more
  • Electronic Health Record Review
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Nov 19, 2021

Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

Recruiting
  • Diffuse Midline Glioma (DMG)
  • +7 more
  • ONC206
  • Standard of Care Radiation Therapy
  • San Francisco, California
  • +2 more
Sep 13, 2022

Breast Carcinoma, Digestive System Tumor, Malignant Brain Tumor Trial in Scottsdale, Jacksonville (Biospecimen Collection,

Active, not recruiting
  • Breast Carcinoma
  • +10 more
  • Biospecimen Collection
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Feb 17, 2022

Cerebrospinal Fluid Biomarkers for Brain Tumors

Recruiting
  • Central Nervous System Neoplasm
  • Biospecimen Collection
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 3, 2021

Malignant CNS Tumor, Primary CNS Tumor Trial in Rochester (Cogstate Assessment Battery, Memantine, Memantine Hydrochloride)

Recruiting
  • Malignant Central Nervous System Neoplasm
  • Primary Central Nervous System Neoplasm
  • Cogstate Assessment Battery
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 21, 2021

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan

Active, not recruiting
  • Childhood Solid Neoplasm
  • +4 more
  • Irinotecan Hydrochloride
  • +4 more
  • Birmingham, Alabama
  • +20 more
Feb 1, 2023